HOME >> MEDICINE >> NEWS
Promising drug fails to thwart fatal lung disease in large trial

DURHAM, N.C. -- A treatment that had shown early promise in alleviating symptoms and preventing the advance of the fatal lung disease pulmonary fibrosis failed to stall the disorder's progression in 162 patients, according to the results of an international clinical trial reported in the Jan. 8, 2004, issue of The New England Journal of Medicine.

Despite the treatment's failure to prevent scarring of the lungs -- a defining characteristic of the disease -- results of the trial did suggest that the drug, known as interferon gamma-1b, might extend the lives of select patients with mild to moderate symptoms, said pulmonologist David A. Schwartz, M.D., who led a portion of the trial at Duke University Medical Center.

"The bottom-line is that interferon gamma does not appear to be effective in slowing progression of pulmonary fibrosis (PF), but could potentially improve survival in patients if caught early in the disease process," Schwartz said.

The study was funded by InterMune Pharmaceuticals, Inc, Brisbane, CA, which manufactures interferon gamma-1b. Dr. Schwartz has been a paid consultant for InterMune since 2000.

PF is an inflammatory disease that results in scarring, or fibrosis, of the lungs. Over time, the fibrosis can progress such that the lungs can no longer deliver oxygen to the body's tissues. Although physicians often treat the disorder with a combination of anti-inflammatory and immunosuppressive therapies, the only clearly effective treatment is lung transplantation, Schwartz said. The median survival time for patients with the disease is two to three years.

PF has multiple causes including exposure to environmental contaminants, such as cigarette smoke and asbestos, and genetic predisposition. The prevalence of the disease is unknown according the National Institutes of Health, but estimates indicate the numbers are rising with as many as 15,000 new cases of idiopathic PF -- a form of the disease having unkno
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-684-4148
Duke University Medical Center
7-Jan-2004


Page: 1 2 3

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Promising treatments for Huntingtons disease identified in UCI study
3. Promising results for malaria vaccine trial
4. Promising diagnostic test for sleeping sickness
5. Promising new treatment options for people with co-existing alcohol-use and psychiatric disorders
6. Promising drug proves ineffective as treatment for hearing loss
7. Promising West Nile virus vaccine protects monkeys
8. Promising new treatment preserves bone mass in mice; May help women and men with osteoporosis
9. Promising vaccine may provide long-lasting protection against malaria
10. Promising new research on schizophrenia causes
11. UI Study Suggests Promising Treatment For Diabetic Pregnancies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2018)... ... December 08, 2018 , ... The ... of telehealth support for pet parents, has become an official supporter of HABRI ... , “By supporting the advancement of human-animal bond research, whiskerDocs is demonstrating its ...
(Date:12/6/2018)... (PRWEB) , ... December 06, 2018 , ... ... to cope with day-to-day life, there are alternative solutions. M.D.-formulated Relaxium Calm is ... Relaxium Calm ’s main ingredient is Sensoril®, an extract of the ashwagandha root. ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... ... Vitae Wellness and Recovery , has been reappointed to serve on Philadelphia Mayor ... policies that support inclusion of those who identify with a cognitive or physical ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... use of the Precision Virtual Reality® medical visualization platform by Surgical Theater. ... physicians with a never-before view of the anatomy and pathology of their ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... training on January 26 at North Monroe Baptist Church, 210 Finks Hideaway Rd, ... part of the agency’s effort to educate and equip faith leaders to address ...
Breaking Medicine News(10 mins):
(Date:11/28/2018)... ... November 28, 2018 , ... CME Outfitters (CMEO), ... new partnership with CME Master, a division of HealthMinds Consulting Pvt. Ltd. to ... South East Asia expected soon. This new collaboration will provide access to top-of-the-line, ...
(Date:11/28/2018)... ... November 28, 2018 , ... All-star ... Medical Center, Tel HaShomer this week to form a collaboration between the hospital’s ... the Democratic Republic of Congo. , On Thursday, November 29, Dikembe Mutombo ...
(Date:11/28/2018)... ... November 29, 2018 , ... Long before wellness tourism and glamping ... hiking spa that was established in the Green Mountains of Vermont in 1978. New ... and share the beauty, serenity and healing that hiking in the Green Mountains provides. ...
Breaking Medicine Technology:
Cached News: